Earningsreport

Q3/2025 9/30/2025 EPS -0.210 ZacksConsensus -0.290 ActVsEst 0.080 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors